Skip to content

Stunned discovery: Aggressive type of lymphoma proves to be challenging

Ex-Television Host Rita Stock reveals her personal struggles following a severe lymphoma diagnosis on the 'Two o'clock in the morning' show.

Struck with surprise, the realization hit hard: this formidable lymphoma shows a significantly...
Struck with surprise, the realization hit hard: this formidable lymphoma shows a significantly aggressive nature.

Stunned discovery: Aggressive type of lymphoma proves to be challenging

Rita Stock, a former television presenter and actress, received a shocking diagnosis in June of this year: aggressive large cell lymphoma of the thymus. The diagnosis came after she felt a sharp pain in her chest in April and sought medical help.

Despite the challenging news, Rita has been resilient. She has been undergoing chemotherapy and is currently feeling well, without fatigue, and able to do physical exercise. Her husband, Francisco, has been providing unwavering support during her treatment.

Rita is a mother of three children: Afonso, Inês, and Tiago. Telling her children about the diagnosis was very difficult for Rita. However, her daughter Inês, in a show of solidarity, made a viral TikTok video about her mother's illness.

Afonso, one of Rita's children, suffered a severe accident in 2014 that left him with sequelae. He was in a coma for three months following the accident. The accident occurred when Afonso was 16 years old and his great-grandfather was taking him to the nearby train station. Tragically, Rita's great-grandfather died instantly in the accident.

After leaving television, Rita created a clothing brand. But her current battle with cancer has not deterred her spirit. She found it less traumatic than expected to shave her head during treatment.

As for the specifics of Rita's clinical status or treatment details, they are not publicly available. General medical knowledge as of 2025 suggests that aggressive large cell lymphoma of the thymus is typically treated with intensive chemotherapy regimens (e.g., CHOP or DA-EPOCH-R), possible addition of targeted therapies (e.g., Rituximab), radiation therapy in certain localized cases, and close monitoring during and post-treatment. The prognosis and treatment plans depend heavily on disease stage, patient's overall health, and response to initial therapy.

Rita's courage and resilience serve as an inspiration to many. Her journey continues, and we wish her a speedy recovery.

Read also:

Latest